Abasaglar KwikPen 100 U/ml

Abasaglar KwikPen 100 U/ml is a medicine authorised by Swissmedic under authorisation number 65069. The authorisation holder is Eli Lilly (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 09 July 2015 and the authorisation is valid without a time limit. ATC code A10AE04 places the medicine in the group Drugs used in diabetes.

  • Dispensing category B
  • Authorisation number 65069
  • ATC A10AE04
  • Biotechnological medicines
Authorisation data
Authorisation number65069
NameAbasaglar KwikPen 100 U/ml
Full nameAbasaglar KwikPen 100 U/ml, solution injectable
Authorisation holderEli Lilly (Suisse) SA
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeA10AE04
First authorisation09 July 2015
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Abasaglar KwikPen 100 U/ml, solution injectableB09 July 2015

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
15 x 3mlA10AE0407.06.1.B
25 x 3mlA10AE0407.06.1.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Abasaglar KwikPen 100 U/ml authorised in Switzerland?

Yes. Abasaglar KwikPen 100 U/ml is authorised by Swissmedic under authorisation number 65069, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Abasaglar KwikPen 100 U/ml have?

Abasaglar KwikPen 100 U/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Abasaglar KwikPen 100 U/ml?

The authorisation holder is Eli Lilly (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com